Free Trial
NASDAQ:GNCA

Genocea Biosciences (GNCA) Stock Price, News & Analysis

Genocea Biosciences logo

About Genocea Biosciences Stock (NASDAQ:GNCA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
83,499 shs
Market Capitalization
$6 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genocea Biosciences and its competitors with MarketBeat's FREE daily newsletter.

GNCA Stock News Headlines

Genocea Biosciences Inc GNCAQ
GNCAQ Genocea Biosciences, Inc.
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Genocea Biosciences, Inc. (GNCA)
GRPN, GNCA and LAB among mid-day movers
Genocea Biosciences to shut down
Genocea Closes Shop, Delists From NASDAQ
See More Headlines

GNCA Stock Analysis - Frequently Asked Questions

Genocea Biosciences, Inc. (NASDAQ:GNCA) posted its quarterly earnings data on Wednesday, October, 27th. The biotechnology company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.15. The biotechnology company had revenue of $1.64 million for the quarter.

Shares of GNCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genocea Biosciences investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), Chipotle Mexican Grill (CMG), BlackRock (BLK), Aegean Marine Petroleum Network (ANW) and Micron Technology (MU).

Company Calendar

Last Earnings
10/27/2021
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GNCA
CIK
1457612
Employees
70
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$33.20 million
Pretax Margin
-1,946.15%

Debt

Sales & Book Value

Annual Sales
$1.91 million
Price / Cash Flow
N/A
Book Value
$0.47 per share
Price / Book
N/A

Miscellaneous

Free Float
57,788,000
Market Cap
$6 thousand
Optionable
Not Optionable
Beta
1.61

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:GNCA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners